New tracheostomy tube improvements designed to meet patient needs
MINNEAPOLIS–(BUSINESS WIRE)–Smiths Medical, a leading global medical device manufacturer, announced today it has launched a new Polyvinyl Chloride (PVC) tracheostomy tube portfolio to its family of tracheostomy tubes. When caring for a patient with a tracheostomy, a tube should be chosen to best suit the patient’s specific clinical need. The new tracheostomy tubes have options for a variety of patients.
“Our goal was to create tracheostomy tubes and kits designed to help clinicians provide the best patient care. We’re excited to offer a variety of tubes and kits that empower clinicians with the ability to practice their way and more importantly, meet their patients’ needs,” said Ellen Frenkel, Chief Marketing Officer.
The Smiths Medical BLUselect® tracheotomy tubes include the following new benefits:
The Smiths Medical BLUperc® and BLUgriggs® percutaneous tracheostomy kits and trays include the following new benefits:
Smiths Medical provides training videos, technique guides, and detailed instructional information for training clinicians on percutaneous insertion. For more information about our new tracheostomy tubes, kits and trays, visit www.smiths-medical.com/bluselect.
About Smiths Medical
A leading supplier of specialized medical devices and equipment for global markets, focusing on the medication delivery, vital care and safety devices market segments. For more information, visit www.smiths-medical.com.
About Smiths Group
A global technology company that has been operating for 160 years, delivering products and services for the medical technology, security & defense, general industrial, energy and space & commercial aerospace markets worldwide. Smiths Group employs c. 22,000 colleagues in over 50 countries and is listed on the London Stock Exchange. For more information visit www.smiths.com.
Contacts
Smiths Medical Media Relations
Ashley Voge, 763-383-3111
media.relations@smiths-medical.com
Vancouver, British Columbia--(Newsfile Corp. - March 26, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB:…
Proposed business combination to create a North American technology company with an AI-driven fintech marketplace.…
NEW YORK, NY / ACCESSWIRE / March 25, 2024 / Chronic pain affects millions of…
Oakville, Ontario--(Newsfile Corp. - March 25, 2024) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF)…
Conference call to discuss financial and operational results scheduled for Tuesday, March 26 at 8:30…
VANCOUVER, BC / ACCESSWIRE / March 25, 2024 / Bruush Oral Care Inc. (NASDAQ:BRSH) (the…